Definity (Lantheus Medical Imaging, Inc.)
Welcome to the PulseAid listing for the Definity drug offered from Lantheus Medical Imaging, Inc.. This Contrast Agent for Ultrasound Imaging [EPC],Ultrasound Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Lantheus Medical Imaging, Inc. |
NON-PROPRIETARY NAME: | perflutren |
SUBSTANCE NAME: | PERFLUTREN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Contrast Agent for Ultrasound Imaging [EPC],Ultrasound Contrast Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SUSPENSION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2001-07-31 |
END MARKETING DATE: | 0000-00-00 |
Definity HUMAN PRESCRIPTION DRUG Details:
Item Description | Definity from Lantheus Medical Imaging, Inc. |
LABELER NAME: | Lantheus Medical Imaging, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6.52(mg/mL) |
START MARKETING DATE: | 2001-07-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 11994-011_c93d3f05-f26b-4ca7-bfac-0f6b95b96418 |
PRODUCT NDC: | 11994-011 |
APPLICATION NUMBER: | NDA021064 |
Other PERFLUTREN Pharmaceutical Manufacturers / Labelers: